Furthermore, Vhl deficiency confers tumor-infiltrating CD8 + T cells with tissue-resident memory T cell-like properties (such as high expression levels of CD103 and CD69) and elicits a better antitumor response [192]. The gene discussed is CD8A; the disease is neoplasm.